Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 13Thoracic 5Other hematologic neoplasm 5Genitourinary 5Gastrointestinal 5Head & Neck 4Tumor-Agnostic 3Lymphoid 3CNS 3Sarcoma 2Gynecologic 2Plasma cell 1Classical hematology 1

Conditions

Fatigue 1Anemia 1

Interventions

Cyclophosphamide 94fludarabine phosphate 87Busulfan 64Cyclosporine 57Epoetin Alfa 55Peripheral Blood Stem Cell Transplantation 54Mycophenolic Acid 54Whole-Body Irradiation 53fludarabine 45Antilymphocyte Serum 43Filgrastim 41Cytarabine 41Melphalan 40Tacrolimus 39Darbepoetin alfa 39Methotrexate 34Radiotherapy 33Cord Blood Stem Cell Transplantation 28Granulocyte Colony-Stimulating Factor 23apixaban 22Methylprednisolone 22Rivaroxaban 21Etoposide 21Thiotepa 17Dalteparin 17eltrombopag 16ferric carboxymaltose 14epoetin beta 14Daunorubicin 14Azacitidine 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Physical Therapy Modalities × Classical hematology × Clear all
NCT00004914 2012-06-06

Exercise Plus Epoetin Alfa in Treating Cancer Patients Who Have Anemia-Related Fatigue

Northwestern University

Phase 2 Completed
Classical hematology

Anemia, Fatigue

Data powered by HemOnc (CC BY 4.0) Colophon âš¡